The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls

被引:18
|
作者
Bettencourt, Conceicao [1 ,2 ,3 ]
Santos, Cristina [1 ,2 ,4 ]
Montiel, Rafael [5 ]
Kay, Teresa [6 ]
Vasconcelos, Joao [7 ]
Maciel, Patricia [8 ]
Lima, Manuela [1 ,2 ,3 ]
机构
[1] Univ Azores, Ctr Res Nat Resources CIRN, P-9501801 Ponta Delgada, Azores, Portugal
[2] Univ Azores, Dept Biol, P-9501801 Ponta Delgada, Azores, Portugal
[3] Univ Porto, IBMC, P-4100 Oporto, Portugal
[4] Univ Autonoma Barcelona, Unitat Antropol Biol, Dep Biol Anim Biol Vegetal & Ecol, E-08193 Barcelona, Spain
[5] CINVESTAV IPN, Lab Nacl Genom Biodiversidad, Irapuato, Mexico
[6] Hosp D Estefania, Dept Clin Genet, Lisbon, Portugal
[7] Hosp Divino Espirito Santo, Dept Neurol, Ponta Delgada, Portugal
[8] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal
关键词
MJD; SCA3; CAG repeats; transcript variation; polyglutamine disorders; CLINICAL-FEATURES; SOMATIC MOSAICISM; AZORES ISLANDS; REPEAT; CEREBELLAR; FAMILIES; SYSTEM; MJD;
D O I
10.1038/ejhg.2009.215
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disorder of late onset (occurring at a mean age of 40.2 years). The clinical manifestation of MJD is dependent on the presence of an expansion of the (CAG)(n) motif within exon 10 of the ATXN3 gene, located at 14q32.1. The variance in onset of MJD is only partially correlated (similar to 50-80%) with the extension of the CAG tract in genomic DNA (gDNA). The main aim of this work was to determine whether there are discrepancies in the size of the (CAG)(n) tract between gDNA and mRNA, and to establish whether there is a better association between age at onset and repeat size at the mRNA level. We typed gDNA and cDNA samples for the (CAG)(n) tract totalizing 108 wild-type and 52 expanded ATXN3 alleles. In wild-type alleles no differences were found between gDNA and cDNA. In expanded alleles, the CAG repeat size in gDNA was not always directly transcribed into the mRNA; on average there were differences of +1 repeat at the cDNA level. The slight discrepancies obtained were insufficient to cause significant differences in the distribution of the expanded alleles, and therefore no improvement in onset variance explanation was obtained with mRNA. European Journal of Human Genetics (2010) 18, 621-623; doi:10.1038/ejhg.2009.215; published online 25 November 2009
引用
收藏
页码:621 / 623
页数:3
相关论文
共 50 条
  • [41] Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3 Machado-Joseph disease
    Cancel, G
    Gourfinkel-An, I
    Stevanin, G
    Didierjean, O
    Abbas, N
    Hirsch, E
    Agid, Y
    Brice, A
    HUMAN MUTATION, 1998, 11 (01) : 23 - 27
  • [42] Variation in the number of CAG repeats in the Machado-Joseph disease gene (MJD1) in the Japanese population
    Matsuyama, Z
    Kawakami, H
    Maruyama, H
    Harada, H
    Nakata, K
    Yamaguchi, Y
    Nakamura, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 166 (01) : 71 - 73
  • [43] Analysis of (CAG)n expansion in ATXN1, ATXN2 and ATXN3 in Chinese patients with multiple system atrophy
    X. Zhou
    C. Wang
    D. Ding
    Z. Chen
    Y. Peng
    H. Peng
    X. Hou
    P. Wang
    X. Hou
    W. Ye
    T. Li
    H. Yang
    R. Qiu
    K. Xia
    J. Sequeiros
    B. Tang
    H. Jiang
    Scientific Reports, 8
  • [44] Analysis of (CAG)n expansion in ATXN1, ATXN2 and ATXN3 in Chinese patients with multiple system atrophy
    Zhou, X.
    Wang, C.
    Ding, D.
    Chen, Z.
    Peng, Y.
    Peng, H.
    Hou, X.
    Wang, P.
    Hou, X.
    Ye, W.
    Li, T.
    Yang, H.
    Qiu, R.
    Xia, K.
    Sequeiros, J.
    Tang, B.
    Jiang, H.
    SCIENTIFIC REPORTS, 2018, 8
  • [45] 特异性基因沉默对Machado-Joseph病ATXN3变异表达的抑制作用
    欧阳嶷
    何志义
    刘嘉晖
    朱华倩
    中国医药导报, 2014, 11 (24) : 16 - 19
  • [46] MODELLING MACHADO-JOSEPH DISEASE IN PATIENT-DERIVED ISOGENIC LINES BY CRISPR/CAS9-MEDIATED CORRETION OF ATXN3-CAG EXPANSION
    Perdigao, Pedro
    Matos, Carlos
    Lopes, Sara
    Fernandes, Rita
    Lopes, Miguel
    Conceicao, Andre
    Faro, Rosario
    Santana, Magda
    Adao, Diana
    Rufino-Ramos, David
    Leandro, Kevin
    Nobre, Rui
    de Almeida, Luis Pereira
    MEDICINE, 2023, 102 (13)
  • [47] A miRNA-based gene therapy approach to knock-down mutant ATXN3: Alleviation of Machado-Joseph disease phenotype in two mouse models upon two routes of administration
    Nobre, Rui Jorge
    Saraiva, Joana
    Fusco, Clelia
    Paixao, Susana
    Santana, Magda
    Miranda, Catarina
    Petrella, Lorena
    Sereno, Jose
    Castelhano, Joao
    Castelo-Branco, Miguel
    Sena-Esteves, Miguel
    Almeida, Luis
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 88 - 89
  • [48] Survival estimates for patients with Machado-Joseph disease (SCA3)
    Kieling, C.
    Prestes, P. R.
    Saraiva-Pereira, M. L.
    Jardim, Laura Bannach
    CLINICAL GENETICS, 2007, 72 (06) : 543 - 545
  • [49] Modifiers of (CAG)n instability in Machado-Joseph disease (MJD/SCA3) transmissions: an association study with DNA replication, repair and recombination genes
    Martins, Sandra
    Pearson, Christopher E.
    Coutinho, Paula
    Provost, Sylvie
    Amorim, Antonio
    Dube, Marie-Pierre
    Sequeiros, Jorge
    Rouleau, Guy A.
    HUMAN GENETICS, 2014, 133 (10) : 1311 - 1318
  • [50] Increased (CTG/CAG)n lengths in myotonic dystrophy type 1 and Machado-Joseph disease genes in idiopathic azoospermia patients
    Pan, HC
    Li, YY
    Li, TC
    Tsai, WT
    Li, SY
    Hsiao, KM
    HUMAN REPRODUCTION, 2002, 17 (06) : 1578 - 1583